Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Identification of Prognostic Factors for Patients Undergoing Ablation for Atrial Fibrillation

NCT05716581 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT05716581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05716581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Identification of Prognostic Factors for Patients Undergoing Ablation for Atrial Fibrillation
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2023
Completion date
March 1, 2026
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, catheter ablation, heart rate variability, spectral analysis, vectorcardiography